Skip to main content
Top
Published in: European Spine Journal 2/2018

01-06-2018 | Original Article

Multidisciplinary management of pyogenic spondylodiscitis: epidemiological and clinical features, prognostic factors and long-term outcomes in 207 patients

Authors: Enrico Pola, F. Taccari, G. Autore, F. Giovannenze, V. Pambianco, R. Cauda, G. Maccauro, M. Fantoni

Published in: European Spine Journal | Special Issue 2/2018

Login to get access

Abstract

Purpose

Pyogenic spondylodiscitis (PS) is a potentially life-threatening infection burdened by high morbidity rates. Despite the rising incidence, the proper management of PS is still controversial. Aim of this study was to describe the clinical features of PS and to evaluate the prognostic factors and the long-term outcomes of a large population of patients.

Methods

207 cases of PS treated from 2008 to 2016 with a 2-year follow-up were enrolled. Clinical data from each patient were recorded. The primary outcome was the rate of healing without residual disability. Secondary outcomes included length of stay, healing from infection, death, relapse, and residual disability. Binomial logistic regression and multivariate analysis were used to evaluate prognostic factors.

Results

Median diagnostic delay was 30 days and the rate of onset neurological impairment was 23.6%. Microbiological diagnosis was established in 155 patients (74.3%) and the median duration of total antibiotic therapy was 148 days. Orthopedic treatment was conservative for 124 patients and surgical in 47 cases. Complete healing without disability was achieved in 142 patients (77.6%). Statistically confirmed negative prognostic factors were: negative microbiological culture, neurologic impairment at diagnosis and underlying endocarditis (p ≤ 0.05). Healing from infection rate was 90.9%, while residual disabilities occurred in 23.5%. Observed mortality rate was 7.8%.

Conclusion

The microbiological diagnosis is the main predictive factor for successful treatment. Early diagnosis and multidisciplinary management are also needed to identify underlying aggressive conditions and to avoid neurological complications associated with poorer long-term outcomes. Despite high healing rates, PS may lead to major disabilities still representing a difficult challenge.

Graphical abstract

These slides can be retrieved under Electronic Supplementary material.
Appendix
Available only for authorised users
Literature
3.
go back to reference Fantoni M, Trecarichi EM, Rossi B, Mazzotta V, Di Giacomo G, Nasto LA, Di Meco E, Pola E (2012) Epidemiological and clinical features of pyogenic spondylodiscitis. Eur Rev Med Pharmacol Sci 16(Suppl 2):2–7PubMed Fantoni M, Trecarichi EM, Rossi B, Mazzotta V, Di Giacomo G, Nasto LA, Di Meco E, Pola E (2012) Epidemiological and clinical features of pyogenic spondylodiscitis. Eur Rev Med Pharmacol Sci 16(Suppl 2):2–7PubMed
10.
go back to reference Nasto LA, Colangelo D, Rossi B, Fantoni M, Pola E (2012) Post-operative spondylodiscitis. Eur Rev Med Pharmacol Sci 16(Suppl 2):50–57PubMed Nasto LA, Colangelo D, Rossi B, Fantoni M, Pola E (2012) Post-operative spondylodiscitis. Eur Rev Med Pharmacol Sci 16(Suppl 2):50–57PubMed
13.
go back to reference Berbari EF, Kanj SS, Kowalski TJ, Darouiche RO, Widmer AF, Schmitt SK, Hendershot EF, Holtom PD, Huddleston PM 3rd, Petermann GW, Osmon DR (2015) Infectious Diseases Society of America. 2015 Infectious Diseases Society of America (IDSA) Clinical Practice Guidelines for the Diagnosis and Treatment of Native Vertebral Osteomyelitis in Adults. Clin Infect Dis 61:e26–e46. https://doi.org/10.1093/cid/civ482 CrossRefPubMed Berbari EF, Kanj SS, Kowalski TJ, Darouiche RO, Widmer AF, Schmitt SK, Hendershot EF, Holtom PD, Huddleston PM 3rd, Petermann GW, Osmon DR (2015) Infectious Diseases Society of America. 2015 Infectious Diseases Society of America (IDSA) Clinical Practice Guidelines for the Diagnosis and Treatment of Native Vertebral Osteomyelitis in Adults. Clin Infect Dis 61:e26–e46. https://​doi.​org/​10.​1093/​cid/​civ482 CrossRefPubMed
16.
go back to reference Leone A, Dell’Atti C, Magarelli N, Colelli P, Balanika A, Casale R, Bonomo L (2012) Imaging of spondylodiscitis. Eur Rev Med Pharmacol Sci 16(Suppl 2):8–19PubMed Leone A, Dell’Atti C, Magarelli N, Colelli P, Balanika A, Casale R, Bonomo L (2012) Imaging of spondylodiscitis. Eur Rev Med Pharmacol Sci 16(Suppl 2):8–19PubMed
19.
go back to reference Bernard L, Dinh A, Ghout I, Simo D, Zeller V, Issartel B, Le Moing V, Belmatoug N, Lesprit P, Bru JP, Therby A, Bouhour D, Dénes E, Debard A, Chirouze C, Fèvre K, Dupon M, Aegerter P, Mulleman D (2015) Duration of Treatment for Spondylodiscitis (DTS) study group (2015) Antibiotic treatment for 6 weeks versus 12 weeks in patients with pyogenic vertebral osteomyelitis: an open-label, non-inferiority, randomised, controlled trial. Lancet 385:875–882. https://doi.org/10.1016/S0140-6736(14)61233-2 CrossRefPubMed Bernard L, Dinh A, Ghout I, Simo D, Zeller V, Issartel B, Le Moing V, Belmatoug N, Lesprit P, Bru JP, Therby A, Bouhour D, Dénes E, Debard A, Chirouze C, Fèvre K, Dupon M, Aegerter P, Mulleman D (2015) Duration of Treatment for Spondylodiscitis (DTS) study group (2015) Antibiotic treatment for 6 weeks versus 12 weeks in patients with pyogenic vertebral osteomyelitis: an open-label, non-inferiority, randomised, controlled trial. Lancet 385:875–882. https://​doi.​org/​10.​1016/​S0140-6736(14)61233-2 CrossRefPubMed
20.
go back to reference Park KH, Cho OH, Lee JH, Park JS, Ryu KN, Park SY, Lee YM, Chong YP, Kim SH, Lee SO, Choi SH, Bae IG, Kim YS, Woo JH, Lee MS (2016) Optimal duration of antibiotic therapy in patients with hematogenous vertebral osteomyelitis at low risk and high risk of recurrence. Clin Infect Dis 62:1262–1269. https://doi.org/10.1093/cid/ciw098 CrossRefPubMed Park KH, Cho OH, Lee JH, Park JS, Ryu KN, Park SY, Lee YM, Chong YP, Kim SH, Lee SO, Choi SH, Bae IG, Kim YS, Woo JH, Lee MS (2016) Optimal duration of antibiotic therapy in patients with hematogenous vertebral osteomyelitis at low risk and high risk of recurrence. Clin Infect Dis 62:1262–1269. https://​doi.​org/​10.​1093/​cid/​ciw098 CrossRefPubMed
21.
go back to reference Roblot F, Besnier JM, Juhel L, Vidal C, Ragot S, Bastides F, Le Moal G, Godet C, Mulleman D, Azaïs I, Becq-Giraudon B, Choutet P (2007) Optimal duration of antibiotic therapy in vertebral osteomyelitis. Semin Arthritis Rheum 36:269–277CrossRefPubMed Roblot F, Besnier JM, Juhel L, Vidal C, Ragot S, Bastides F, Le Moal G, Godet C, Mulleman D, Azaïs I, Becq-Giraudon B, Choutet P (2007) Optimal duration of antibiotic therapy in vertebral osteomyelitis. Semin Arthritis Rheum 36:269–277CrossRefPubMed
22.
go back to reference Grados F, Lescure FX, Senneville E, Flipo RM, Schmit JL, Fardellone P (2007) Suggestions for managing pyogenic (non-tuberculous) discitis in adults. Joint Bone Spine 74:133–139CrossRefPubMed Grados F, Lescure FX, Senneville E, Flipo RM, Schmit JL, Fardellone P (2007) Suggestions for managing pyogenic (non-tuberculous) discitis in adults. Joint Bone Spine 74:133–139CrossRefPubMed
23.
go back to reference Pola E, Logroscino CA, Gentiempo M, Colangelo D, Mazzotta V, Di Meco E, Fantoni M (2014) Medical and surgical treatment of pyogenic spondylodiscitis. Eur Rev Med Pharmacol Sci 16(Suppl 2):35–49 Pola E, Logroscino CA, Gentiempo M, Colangelo D, Mazzotta V, Di Meco E, Fantoni M (2014) Medical and surgical treatment of pyogenic spondylodiscitis. Eur Rev Med Pharmacol Sci 16(Suppl 2):35–49
24.
Metadata
Title
Multidisciplinary management of pyogenic spondylodiscitis: epidemiological and clinical features, prognostic factors and long-term outcomes in 207 patients
Authors
Enrico Pola
F. Taccari
G. Autore
F. Giovannenze
V. Pambianco
R. Cauda
G. Maccauro
M. Fantoni
Publication date
01-06-2018
Publisher
Springer Berlin Heidelberg
Published in
European Spine Journal / Issue Special Issue 2/2018
Print ISSN: 0940-6719
Electronic ISSN: 1432-0932
DOI
https://doi.org/10.1007/s00586-018-5598-9

Other articles of this Special Issue 2/2018

European Spine Journal 2/2018 Go to the issue